Wendell Wierenga

Director, Dermata Therapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 1, 2026Returned to company 5,925 shares at $85.00 of Crinetics Pharmaceuticals⁶
Sep 1, 2026Returned to company 116,146 shares at $85.00 of Crinetics Pharmaceuticals⁶
Jul 15, 2026Granted 75 shares at $82.62 of Cytokinetics⁴
Jun 18, 2026Granted 5,925 shares of Crinetics Pharmaceuticals⁷
May 27, 2026Granted 2,851 shares of Cytokinetics⁸
May 5, 2026Sold 4,032 shares at $75.00 of Cytokinetics⁹
May 5, 2026Exercised options 4,032 shares at $12.40 of Cytokinetics⁹
Apr 15, 2026Granted 95 shares at $65.37 of Cytokinetics¹⁰
Jan 15, 2026Granted 98 shares at $63.44 of Cytokinetics¹¹
Dec 22, 2025Sold 20,000 shares at $66.14 of Cytokinetics¹²
Dec 22, 2025Exercised options 20,000 shares at $7.61 of Cytokinetics¹²
Oct 27, 2025Sold 4,375 shares at $58.68 of Cytokinetics¹³
Oct 27, 2025Exercised options 4,375 shares at $10.00 of Cytokinetics¹³
Oct 15, 2025Granted 99 shares at $62.80 of Cytokinetics¹⁴
Oct 6, 2022Granted 20,654 shares of Dermata Therapeutics, Inc.⁵
Jul 7, 2022Granted 18,110 shares of Dermata Therapeutics, Inc.¹⁵
Apr 7, 2022Granted 10,593 shares of Dermata Therapeutics, Inc.¹⁶

The numbers on this page point here. Each one links to the record it came from.